Concepedia

Publication | Open Access

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

DOIFull Paper Access

41

Citations

22

References

2014

Year

Suxia Han, Jun-lan Wang, Xijing Guo, Chenchen He, Xia Ying, Jinlu Ma, Yuanyuan Zhang, Qian Zhao, Qing Zhu
Journal of Immunology Research

Abstract

High SALL4 serum levels are a novel biomarker in the prognosis of HCC patients.

References

YearCitations

Page 1